Raymond F Schinazi

5PUBLICATIONS
17CO-AUTHORS
Nanotoxicology, health and safetyBiologically active moleculesHaematological tumoursCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 01, 2026
The 5'-Isobutyryl Ester Prodrug of 4'-Thiouridine Inhibits SARS-CoV‑2 Replication in Culture and in a Syrian Hamster Infection Model.

|May 18, 2026
Stereoselective synthesis of 1'-α-cyano carbocyclic pyrimidine nucleoside analogs via a chelation-controlled 1'-α-hydroxymethylation strategy.

|Jan 05, 2026
Prodrug strategies in developing antiviral nucleoside analogs.

R Rama Suresh, Tuniyazi Abuduani, Mahesh Kasthuri

|Nov 06, 2025
Novel Dimeric Capsid Assembly Modulators as a Unique Class of Highly Potent Anti-HBV Agents.

Franck Amblard, Zhe Chen, Kalouna Kra

|Oct 03, 2025
1'-Cyanocytidine-5'-isobutyryl is a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamsters.

Franck Amblard, Mahesh Kasthuri, Julia C LeCher

Pageof 1

Frequent Collaborators

3 joint publications

Raymond F Schinazi

2 joint publications

Dharmeshkumar Patel

1 joint publications

Julia C LeCher

1 joint publications

Rana Abdelnabi